Menlo Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-66,410
Closed -$5.74M 44
2016
Q3
$5.74M Sell
66,410
-480
-0.7% -$41.8K 4.6% 5
2016
Q2
$5.8M Sell
66,890
-101
-0.2% -$8.17K 4.93% 4
2016
Q1
$5.02M Sell
66,991
-80
-0.1% -$6.03K 4.61% 5
2015
Q4
$5.16M Sell
67,071
-6,315
-9% -$475K 4.54% 7
2015
Q3
$4.91M Sell
73,386
-1,220
-2% -$89.9K 3.86% 9
2015
Q2
$5.53M Sell
74,606
-21,755
-23% -$1.66M 3.87% 11
2015
Q1
$7.51M Buy
96,361
+1,046
+1% +$79.3K 5.37% 3
2014
Q4
$6.88M Sell
95,315
-600
-0.6% -$41.7K 4.89% 4
2014
Q3
$5.94M Sell
95,915
-525
-0.5% -$33.4K 4.31% 8
2014
Q2
$6.15M Hold
96,440
4.41% 6
2014
Q1
$5.93M Sell
96,440
-1,660
-2% -$96.7K 4.45% 7
2013
Q4
$5.63M Hold
98,100
4.2% 10
2013
Q3
$5.22M Buy
98,100
+27,310
+39% +$1.47M 4.07% 9
2013
Q2
$3.64M Buy
+70,790
New +$3.5M 3.07% 16

Other funds holding MDT

Menlo Advisors's MDT Position: Q4 2016 in Review

Menlo Advisors sold out of Medtronic (MDT) in Q4 2016, closing a stake of 66,410 shares — an estimated $5.74M sold.

Menlo Advisors first reported a position in MDT in Q2 2013 and held it in 14 quarters. The position peaked at $7.51M in Q1 2015. 1,269 funds tracked by Wall St. Rank hold MDT as of Q4 2016.

  • Menlo Advisors reported no remaining Medtronic position as of Q4 2016 after selling out during the quarter.
  • Menlo Advisors sold 66,410 Medtronic shares in Q4 2016, an estimated $5.74M.
  • Menlo Advisors first reported a position in Medtronic in Q2 2013 and held it in 14 quarters.
  • Menlo Advisors's Medtronic position peaked at $7.51M in Q1 2015.
  • 1,269 funds tracked by Wall St. Rank held Medtronic as of Q4 2016.

Based on Menlo Advisors's 13F filing for Q4 2016, filed 23 Jan 2017.